Medscape Oncology

How similar are biosimilars to the index drug? Drs David Kerr and Håkan Mellstedt talk about how biosimilars are developed, regulated, and priced -- and whether they can be trusted by physicians.

From screening to treatment, breast cancer specialist Laura Esserman is on a quest to individualize patient care, and in doing so she is challenging a number of long-standing practices in cancer care.

Healthcare providers have a role in improving psychosocial outcomes of cancer survivors by identifying and addressing distress.

In a preview of ASCO melanoma studies, the NEMO results suggest that binimetinib is reasonable for NRAS-mutated melanoma, and combo regimens continue to show strong outcomes, reports Dr Jeffrey Weber.

Dr Sheetal Kircher gives tips for making the most out of the American Society of Clinical Oncology (ASCO) annual meeting and enjoying her hometown, Chicago.

Dr Alan Jacobs discusses an experimental study evaluating a high-fat, low-carbohydrate diet in mice with glioblastoma.

Dr Jeffrey Weber, Medscape's new commentator on melanoma and immunotherapy, discusses impressive data on overall survival and combination therapy presented at AACR 2016.

By leading an unprecedented group of companies, institutions, and scientists in Cancer Moonshot 2020, Patrick Soon-Shiong has set out to change cancer care forever. Here's how he plans to do it.

Drs Kathy Miller and Bryan Schneider discuss the surprising CREATE-X findings, which show improved survival using more chemotherapy in triple-negative breast cancer patients with residual disease.

Does the Medscape Lifestyle Report reflect the real issues of oncologists? Dr Sheetal Kircher takes a survey of her colleagues and finds work-life balance is hard to achieve at all stages of a career.